Terms: = Brain cancer AND TIMP1, CLGI, EPA, EPO, HCI, TIMP, TIMP-1 AND Prognosis
28 results:
1. Identification and validation of anoikis-related genes to clarify the prognosis and immune mechanisms of patients with low-grade glioma.
Wang J; Liu Y; Qian M; Xu W; Chen J; Deng Y; Luo R; Chen J; Jia W; Liu L; Tian C
Biochem Biophys Res Commun; 2024 Jun; 711():149894. PubMed ID: 38603834
[TBL] [Abstract] [Full Text] [Related]
2. timp1/CHI3L1 facilitates glioma progression and immunosuppression via NF-κB activation.
Xu J; Wei C; Wang C; Li F; Wang Z; Xiong J; Zhou Y; Li S; Liu X; Yang G; Han L; Zhang J; Zhang S
Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):167041. PubMed ID: 38290591
[TBL] [Abstract] [Full Text] [Related]
3. High levels of timp1 are associated with increased extracellular matrix stiffness in isocitrate dehydrogenase 1-wild type gliomas.
Luo CH; Shi Y; Liu YQ; Liu Q; Mao M; Luo M; Yang KD; Wang WY; Chen C; Niu Q; Yan ZX; Miao JY; Zhang XN; Zeng H; Li L; Bian XW; Ping YF
Lab Invest; 2022 Dec; 102(12):1304-1313. PubMed ID: 35882906
[TBL] [Abstract] [Full Text] [Related]
4. Identification of FABP7 as a Potential Biomarker for Predicting prognosis and Antiangiogenic Drug Efficacy of Glioma.
Hou L; Zhou H; Wang Y; Liu J; Zhang D; Li Y; Xue X
Dis Markers; 2022; 2022():2091791. PubMed ID: 35783014
[TBL] [Abstract] [Full Text] [Related]
5. Identification of Molecular Subtypes and a Prognostic Signature Based on Inflammation-Related Genes in Colon Adenocarcinoma.
Qiu C; Shi W; Wu H; Zou S; Li J; Wang D; Liu G; Song Z; Xu X; Hu J; Geng H
Front Immunol; 2021; 12():769685. PubMed ID: 35003085
[TBL] [Abstract] [Full Text] [Related]
6. Identification of Autophagy-Related Prognostic Signature and Analysis of Immune Cell Infiltration in Low-Grade Gliomas.
Quan Q; Xiong X; Wu S; Yu M
Biomed Res Int; 2021; 2021():7918693. PubMed ID: 34790823
[TBL] [Abstract] [Full Text] [Related]
7. Ensemble based machine learning approach for prediction of glioma and multi-grade classification.
Chandra Joshi R; Mishra R; Gandhi P; Pathak VK; Burget R; Dutta MK
Comput Biol Med; 2021 Oct; 137():104829. PubMed ID: 34508971
[TBL] [Abstract] [Full Text] [Related]
8. Identification of Hub Genes of Mesio Temporal Lobe Epilepsy and Prognostic Biomarkers of brain Low-grade Gliomas Based on Bioinformatics Analysis.
Xu J; Sun M; Wang Y; Xie A; Gao J
Cell Transplant; 2020; 29():963689720978722. PubMed ID: 33327771
[TBL] [Abstract] [Full Text] [Related]
9. Increased expression of MMP-2 and MMP-9 indicates poor prognosis in glioma recurrence.
Zhou W; Yu X; Sun S; Zhang X; Yang W; Zhang J; Zhang X; Jiang Z
Biomed Pharmacother; 2019 Oct; 118():109369. PubMed ID: 31545229
[TBL] [Abstract] [Full Text] [Related]
10. Expressions of Matrix Metalloproteinases-9 and Tissue Inhibitor of Metalloproteinase-1 in Pituitary Adenomas and Their Relationships with prognosis.
Guo H; Sun Z; Wei J; Xiang Y; Qiu L; Guo L; Zhao W; Xu Z; Mao J
Cancer Biother Radiopharm; 2019 Feb; 34(1):1-6. PubMed ID: 30676069
[TBL] [Abstract] [Full Text] [Related]
11. Overexpression of timp-1 and Sensitivity to Topoisomerase Inhibitors in Glioblastoma Cell Lines.
Aaberg-Jessen C; Fogh L; Sørensen MD; Halle B; Brünner N; Kristensen BW
Pathol Oncol Res; 2019 Jan; 25(1):59-69. PubMed ID: 28963609
[TBL] [Abstract] [Full Text] [Related]
12. Expression and prognostic impact of matrix metalloproteinase-2 (MMP-2) in astrocytomas.
Ramachandran RK; Sørensen MD; Aaberg-Jessen C; Hermansen SK; Kristensen BW
PLoS One; 2017; 12(2):e0172234. PubMed ID: 28234925
[TBL] [Abstract] [Full Text] [Related]
13. Comparative studies of timp-1 immunohistochemistry, timp-1 FISH analysis and plasma timp-1 in glioblastoma patients.
Aaberg-Jessen C; Halle B; Jensen SS; Müller S; Rømer UM; Pedersen CB; Brünner N; Kristensen BW
J Neurooncol; 2016 Dec; 130(3):439-448. PubMed ID: 27619981
[TBL] [Abstract] [Full Text] [Related]
14. Naringin inhibits the invasion and migration of human glioblastoma cell via downregulation of MMP-2 and MMP-9 expression and inactivation of p38 signaling pathway.
Aroui S; Najlaoui F; Chtourou Y; Meunier AC; Laajimi A; Kenani A; Fetoui H
Tumour Biol; 2016 Mar; 37(3):3831-9. PubMed ID: 26474590
[TBL] [Abstract] [Full Text] [Related]
15. Knockdown of the AKT3 (PKBγ), PI3KCA, and VEGFR2 genes by RNA interference suppresses glioblastoma multiforme T98G cells invasiveness in vitro.
Paul-Samojedny M; Pudełko A; Suchanek-Raif R; Kowalczyk M; Fila-Daniłow A; Borkowska P; Kowalski J
Tumour Biol; 2015 May; 36(5):3263-77. PubMed ID: 25501707
[TBL] [Abstract] [Full Text] [Related]
16. Incidence and prognostic value of multiple gene promoter methylations in gliomas.
Zhang L; Wang M; Wang W; Mo J
J Neurooncol; 2014 Jan; 116(2):349-56. PubMed ID: 24197988
[TBL] [Abstract] [Full Text] [Related]
17. Interaction of brain fatty acid-binding protein with the polyunsaturated fatty acid environment as a potential determinant of poor prognosis in malignant glioma.
Elsherbiny ME; Emara M; Godbout R
Prog Lipid Res; 2013 Oct; 52(4):562-70. PubMed ID: 23981365
[TBL] [Abstract] [Full Text] [Related]
18. B7-H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis-associated genes.
Tekle C; Nygren MK; Chen YW; Dybsjord I; Nesland JM; Maelandsmo GM; Fodstad O
Int J Cancer; 2012 May; 130(10):2282-90. PubMed ID: 21671471
[TBL] [Abstract] [Full Text] [Related]
19. Adult grade II diffuse astrocytomas are genetically distinct from and more aggressive than their paediatric counterparts.
Jones DT; Mulholland SA; Pearson DM; Malley DS; Openshaw SW; Lambert SR; Liu L; Bäcklund LM; Ichimura K; Collins VP
Acta Neuropathol; 2011 Jun; 121(6):753-61. PubMed ID: 21327941
[TBL] [Abstract] [Full Text] [Related]
20. timp-4 and CD63: new prognostic biomarkers in human astrocytomas.
Rorive S; Lopez XM; Maris C; Trepant AL; Sauvage S; Sadeghi N; Roland I; Decaestecker C; Salmon I
Mod Pathol; 2010 Oct; 23(10):1418-28. PubMed ID: 20693981
[TBL] [Abstract] [Full Text] [Related]
[Next]
